Question 1

What is the catalog number for 3,29-O-dibenzoyloxysokarounidiol?

Accepted Answer

The catalog number for 3,29-O-dibenzoyloxysokarounidiol is M38861.

Question 2

What sizes are available for 3,29-O-dibenzoyloxysokarounidiol?

Accepted Answer

3,29-O-dibenzoyloxysokarounidiol is available in the following size(s): 100 mg, 25 mg, 50 mg, 500 mg, Inquire.

Question 3

How many pack sizes does 3,29-O-dibenzoyloxysokarounidiol come in?

Accepted Answer

3,29-O-dibenzoyloxysokarounidiol is available in 5 different pack sizes.

Question 4

Is 3,29-O-dibenzoyloxysokarounidiol in stock?

Accepted Answer

3,29-O-dibenzoyloxysokarounidiol is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is 3,29-O-dibenzoyloxysokarounidiol used for?

Accepted Answer

3,29-O-dibenzoyloxysokarounidiol

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 8

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

3,29-O-dibenzoyloxysokarounidiol

Product Specifications

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Frequently Asked Questions

Explore Other Products

CD20 (IGEL/773), CF647 conjugate, 0.1mg/mL

Human Kappa Light Chain (KLC264), CF640R conjugate, 0.1mg/mL

SUMO-2/3 (SM23/496), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF568 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

Thyroglobulin (Thyroidal Cell Marker) (TGB/1968R), CF740 conjugate, 0.1mg/mL